High-dose moxalactam in gram-negative pneumonia: efficacy and safety.

D. K. Payne, L. E. Vereen, R. B. George, J. R. Lentino, J. P. O'Keefe, F. R. Venezio, J. Rotschafer

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)293-295
Number of pages3
JournalDrug intelligence & clinical pharmacy
Volume21
Issue number3
DOIs
StatePublished - Mar 1987

Cite this

Payne, D. K., Vereen, L. E., George, R. B., Lentino, J. R., O'Keefe, J. P., Venezio, F. R., & Rotschafer, J. (1987). High-dose moxalactam in gram-negative pneumonia: efficacy and safety. Drug intelligence & clinical pharmacy, 21(3), 293-295. https://doi.org/10.1177/106002808702100316